نتایج جستجو برای: her2 receptor

تعداد نتایج: 599649  

Journal: :Cancer research 2009
Shizhen Emily Wang Bin Xiang Roy Zent Vito Quaranta Ambra Pozzi Carlos L Arteaga

It has been proposed that cross talk between integrin and growth factor receptor signaling such as ErbB2 (HER2) is required for activation of downstream effectors and ErbB2-mediated mammary tumorigenesis. Here we show that transforming growth factor beta (TGF-beta) induced focal adhesion kinase (FAK)-dependent clustering of HER2 and integrins alpha(6), beta(1), and beta(4) in HER2-overexpressin...

Journal: :International journal of oncology 2009
Richard E Francis Stephen S Myatt Janna Krol Johan Hartman Barrie Peck Ursula B McGovern Jun Wang Stephanie K Guest Aleksandra Filipovic Ondrej Gojis Carlo Palmieri David Peston Sami Shousha Qunyan Yu Piotr Sicinski R Charles Coombes Eric W-F Lam

The tyrosine kinase receptor, HER2 is a crucial prognostic marker and therapeutic target for breast cancer; however, the downstream targets and biological effectors of HER2 remain unclear. We investigated the relationship between HER2 and the transcription factor FoxM1 in breast cancer. HER2 and FoxM1 expression levels were compared in breast carcinoma cell lines, paraffin-embedded breast cance...

2009
Shizhen Emily Wang Bin Xiang Roy Zent Vito Quaranta Ambra Pozzi Carlos L. Arteaga

It has been proposed that cross talk between integrin and growth factor receptor signaling such as ErbB2 (HER2) is required for activation of downstream effectors and ErbB2mediated mammary tumorigenesis. Here we show that transforming growth factor B (TGF-B) induced focal adhesion kinase (FAK)–dependent clustering of HER2 and integrins A6, B1, and B4 in HER2-overexpressing mammary epithelial ce...

Journal: :The Journal of biological chemistry 1992
T Spivak-Kroizman D Rotin D Pinchasi A Ullrich J Schlessinger I Lax

Ligand-induced dimerization of growth factor receptors is crucial for stimulation of their intrinsic protein tyrosine kinase activity promoting receptor autophosphorylation by an intermolecular mechanism. Moreover, the suppressive and negative dominant action of defective epidermal growth factor receptor (EGFR) was shown to be caused by formation of inactive heterodimers with normal EGFR leadin...

Journal: :Computational and structural biotechnology journal 2021

A protein binder with a desired epitope and binding affinity is critical to the development of therapeutic agents. Here we present computationally-guided design improvement recognizing specific site on domain IV human epidermal growth factor receptor 2 (HER2). As model, scaffold composed Leucine-rich repeat (LRR) modules was used. We designed binders which appear bind target using computational...

2016
Yogin Patel Nirav Shah Ji Shin Lee Eleni Markoutsa Chunfa Jie Shou Liu Rachel Botbyl David Reisman Peisheng Xu Hexin Chen

Human epidermal growth factor receptor 2 (HER2 or ErBb2) is a receptor tyrosine kinase overexpressed in 20-30% of breast cancers and associated with poor prognosis and outcome. Dysregulation of several microRNAs (miRNAs) plays a key role in breast cancer progression and metastasis. In this study, we screened and identified miRNAs dysregualted in HER2-positive breast cancer cells. Our molecular ...

2011
A. Jouret - Mourin A. Hoorens M. Kockx P. Demetter E. Van

1 4 Introduction Human epidermal growth factor receptor 2 (HER2, ErbB2, Neu) is a 185-kDa transmembrane tyrosine kinase receptor. It is a member of the EGFR family and plays a central role in growth factor signal transduction. HER2 overexpression/amplification is implicated in the development of various solid tumours and plays a pivotal role in oncogenic transformation and tumorogenesis.1 The H...

Journal: :Translational oncology 2010
Daniela Meco Tiziana Servidei Gian Franco Zannoni Enrica Martinelli Maria Grazia Prisco Chiara de Waure Riccardo Riccardi

Medulloblastoma is the most frequent malignant pediatric brain tumor with a dismal prognosis in 30% of cases. We examined the activity of AEE788, a dual inhibitor of human epidermal receptor (HER) 1/2 and vascular endothelial growth factor receptor (VEGFR) 1/2, in medulloblastoma preclinical models. Established lines (Daoy and D283), chemoresistant (Daoy(Pt)), and ectopically HER2-overexpressin...

Journal: :Cancer research 2002
Nerissa Mendoza Gail Lewis Phillips Johnny Silva Ralph Schwall Dineli Wickramasinghe

Hormone-independent tumor growth and metastasis are associated with increased mortality in human prostate cancer. In this study, we evaluate a potential role for ligand-mediated activation of HER2 receptor tyrosine kinase in androgen-independent prostate cancers. HER2, HER3, and epidermal growth factor receptor were detected in the androgen-independent cell line 22Rv1. Heregulin stimulation res...

Journal: :Oncology reports 2008
Isabella Castellano Anna Sapino Riccardo Arisio Giuseppe Viale Gianni Bussolati Roberto Bandelloni Gaetano Barresi Alessandra Bersiga Cesare Bordi Gerardo Botti Fabia Cosimi Emanuele D'Amore Claudio Doglioni Antonio Marchetti Oscar Nappi Francesco Romeo Massimo Roncalli Rosa Russo Alfredo Santinelli Luigi Giusto Spagnoli Francesco Tanda Paolo Tricomi Gianpaolo Trentini Fabrizio Zanconati Monica Iurlaro

The aim of the present study was to evaluate the effectiveness of fluorescence in situ hybridisation (FISH), as a screening test, in moderately- (G2) or poorly- (G3) differentiated breast cancers of the ductal (IDC) and lobular (ILC) histotypes and distant metastases. HER2 FISH was performed on 486 G2 and 477 G3 both of IDC and ILC histotypes and in 241 metastases. A significant difference in t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید